1. Ikoma, A. et al. The neurobiology of itch. Nat Rev Neurosci 7, 535-547 (2006).
2. Kini SP et al. The impact of pruritus on quality of life: the skin equivalent of pain. Arch Dermatol 147, 1153‒1156 (2011).
3. Ikoma, A. Updated neurophysiology of itch. Biol Pharm Bull 36, 1235‒1240 (2013).
4. Liu, T. and Ji, R. R. New insights into the mechanisms of itch: are pain and itch controlled by distinct mechanisms? Pflugers Arch 465, 1671-1685 (2013).
5. Alving, K. et al. Association between histamine-containing mast cells and sensory nerves in the skin and airways of control and capsaicin-treated pigs.
Cell Tissue Res 264, 529‒538 (1991).
6. Paus, R. et al. Frontiers in pruritus research: scratching the brain for more effective itch therapy. J Clin Invest 116, 1174‒1185 (2006).
7. Meixiong, J. et al. Activation of Mast-Cell-Expressed Mas-Related
G-Protein-Coupled Receptors Drives Non-histaminergic itch. Immunity 50, 1-9 (2019).
8. Martin, T. W. and Lagunoff, D. Interactions of lysophospholipids and mast cells. Nature 279, 250-252 (1979).
9. Makide, K. et al. Novel lysophosphoplipid receptors: their structure and function. J lipid Res 55, 1986-1995 (2014).
10. Iwashita, M. et al. Synthesis and evaluation of lysophosphatidylserine analogues as inducers of mast cell degranulation. Potent activities of
lysophosphatidylthreonine and its 2-deoxy derivative. J Med Chem 52, 5837‒
5863 (2009).
11. Sugo, T. et al. Identification of a lysophosphatidylserine receptor on mast cells.Biochem Biophys Res Commun 341, 1078-1087 (2006).
12. Inoue, A. et al. TGFa shedding assay: an accurate and versatile method for detecting GPCR activation. Nat Methods 9, 1021-1029 (2012).
13. Uwamizu, A. et al. Lysophosphatidylserine analogues differentially activate three LysoPS receptors. J Biochem 157, 151‒ 160 (2015).
14. Ikubo, M. et al. Structure-activity relationships of lysophosphatidylserine analogs as agonists of G-protein-coupled receptors GPR34, P2Y10, and GPR174. J Med Chem 58, 4204‒ 4219 (2015).
15. Kishi, T. et al. Identification of lysophosphatidylthreonine with an aromatic fatty acid surrogate as a potent inducer of mast cell degranulation.
Biochemistry and Biophysics Reports 8, 346-351 (2016).
16. Bowser, P. A. et al. Identification, isolation and characterization of epidermal lipids containing linoleic acid. Biochim Biophys Acta 834, 419-428 (1985).
17. Shapiro, H. et al. Beyond the classic eicosanoids: Peripherally-acting oxygenated metabolites of polyunsaturated fatty acids mediate pain associated with tissue injury and inflammation. Prostaglandins Leukot.
Essent. Fatty Acids 111, 45‒61 (2016).
18. Ramsden, C. E. et al. A systems approach for discovering linoleic acid derivatives that potentially mediate pain and itch. Sci Signal 10, eaal5241 (2017).
19. Hirabayashi, T. et al. The role of PNPLA1 in ω-O-acylceramide synthesis and skin barrier function. Biochim Biophys Acta Mol Cell Biol Lipids 1864, 869-879 (2019).
20. Yunhi Cho and Vincent A. Ziboh. Incorporation of
13-hydroxyoctadecadienoic acid (13-HODE) into epidermal ceramides and phospholipids: phospholipase C-catalyzed release of novel 13-HODE-containing diacylglycerol. J Lipid Res 35, 255-262 (1994).
21. Imamachi, N. et al. TRPV1-expressing primary afferents generate behavioral responses to pruritogens via multiple mechanisms. Proc Natl Acad Sci U S A 106, 11330-11335 (2009).
22. Frederik De Jonge et al., Effect of intestinal inflammation on capsaicin-sensitive afferents in the ileum of Schistosoma mansoni-infected mice.
Histochem Cell Biol 119, 477-484 (2003).
23. Devost, D. et al. Conformational Profiling of the AT1 Angiotensin II Receptor Reflects Biased Agonism, G Protein Coupling, and Cellular Context. J Biol Chem 292, 5443-5456 (2017).
24. Schrage, R. et al. The experimental power of FR900359 to study Gq-regulated biological processes. Nat Commun 6, 10156 (2015).
25. Zhu, Y. et al. Mrgprs activation is required for chronic itch conditions in mice. Itch (Phila) 2, (2017).
26. Kawana, H. et al. An accurate and versatile method for determining the acyl group-introducing position of lysophospholipid acyltransferases. Biochim Biophys Acta Mol Cell Biol Lipids 1864, 1053-1060 (2019).
27. Steven G. Shimada and Robert H. LaMotte. Behavioral differentiation between itch and pain in mouse. Pain 139, 681-687 (2008).
28. Kitamura, Y. et al. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood 52, 447-452 (1978).
29. Shiratori-Hayashi, M. et al. STAT3-dependent reactive astrogliosis in the spinal dorsal horn underlies chronic itch. Nat Med 21, 927-931 (2015).
30. Jing Feng et al. Sensory TRP channels contribute differentially to skin inflammation and persistent itch. Nat Commun 8, 980 (2017).
31. Nicholas K. Mollanazar et al. Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out? Clinic Rev Allerg Immunol 51, 263-292 (2016).
32. Dong, X. et al. A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons. Cell 106, 619-632 (2001).
33. Zylka, M. et al. Atypical expansion in mice of the sensory neuron-specific Mrg G protein-coupled receptor family. Proc Natl Acad Sci U S A 100, 10043-10048 (2003).
34. Liu, Q. et al. Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus. Cell 139, 1353-1365 (2009).
35. James Meixiong and Xinzhong Dong. Mas-Related G Protein-Coupled Receptors and the Biology of Itch Sensation. Annu Rev Genet 51, 103-121 (2017).
36. Meixiong, J. et al. Identification of a bilirubin receptor that may mediate a component of cholestatic itch. eLife 8 (2019).
37. Meixiong, J. et al. MRGPRX4 is a G protein-coupled receptor activated by bile acids that may contribute to cholestatic pruritus. Proc Natl Acad Sci U S A 116, 10525-10530 (2019).
38. Liang Han et al. Mrgprs on vagal sensory neurons contribute to
bronchoconstriction and airway hyper-responsiveness. Nat Neurosci 21, 324-328 (2018).
39. Benjamin D. McNeil et al. Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions. Nature 519, 237-241 (2015).
40. Liu, Q. et al. The Distinct Roles of Two GPCRs, MrgprC11 and PAR2, in Itch and Hyperalgesia. Sci Signal 181, ra45 (2011).
41. O'Donnell, V. B. et al. Enzymatically oxidized phospholipids assume center stage as essential regulators of innate immunity and cell death. Sci Signal 12 (2019).
42. Tereza Bautzova et al. 5-oxoETE triggers nociception in constipation-predominant irritable bowel syndrome through MAS-related G protein-coupled receptor D. Sci Signal 11, eaal2171 (2018).
43. G. Yosipovitch. Dry skin and impairment of barrier function associated with itch-new insights. International Journal of Cosmetic Science 26, 1-7 (2004).
44. Honda, T. et al. Update of Immune Events in the Murine Contact Hypersensitivity Model: Toward the Understanding of Allergic Contact Dermatitis. J Invest Dermatol 133, 303-315 (2013).
45. Bart N. Lambrecht and Hamida Hammad. Eur J Immunol 43, 3125‒3137 (2013).
46. ⽯⿊純 東北⼤学⼤学院薬学研究科 修⼠学位論⽂（2011 年度）
47. W. K. Kroeze et al. PRESTO-TANGO: an open-source resource for interrogation of the druggable human GPCR-ome. Nat Struct Mol Biol 5, 362-369 (2015).
48. Guan, Y. et al. Mas-related G-protein-coupled receptors inhibit pathological pain in mice. Proc Natl Acad Sci U S A 114, 15-15938 (2010).
49. Li, Z. et al. Targeting human Mas-related G protein-coupled receptor X1 to inhibit persistent pain. Proc Natl Acad Sci U S A 114, E1996-E2005 (2017).